Quantbot Technologies’s Aimmune Therapeutics AIMT Stock Holding History

Quantbot Technologies’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,810	Closed	-$96K	–	1852
2020 Q3	$96K	Buy	+2,810	New	+$59.8K	0.01%	739
2018 Q4	–	Sell	-3,261	Closed	-$88K	–	1585
2018 Q3	$88K	Buy	+3,261	New	+$92.2K	0.01%	914
2018 Q2	–	Sell	-169	Closed	-$5K	–	1629
2018 Q1	$5K	Sell	169 -3,712	-96%	-$131K	﹤0.01%	1138
2017 Q4	$146K	Buy	+3,881	New	+$125K	0.01%	772
2017 Q1	–	Sell	-5,002	Closed	-$102K	–	1507
2016 Q4	$102K	Buy	+5,002	New	+$102K	0.01%	708

Quantbot Technologies's AIMT Position: Q4 2020 in Review

Quantbot Technologies sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 2,810 shares — an estimated $96K sold.

Quantbot Technologies first reported a position in AIMT in Q4 2016 and held it in 5 quarters. The position peaked at $146K in Q4 2017. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Quantbot Technologies reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Quantbot Technologies sold 2,810 Aimmune Therapeutics shares in Q4 2020, an estimated $96K.
Quantbot Technologies first reported a position in Aimmune Therapeutics in Q4 2016 and held it in 5 quarters.
Quantbot Technologies's Aimmune Therapeutics position peaked at $146K in Q4 2017.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Quantbot Technologies's 13F filing for Q4 2020, filed 12 Feb 2021.